Navigation Links
Zimmer Reports Fourth Quarter and 2007 Financial Results
Date:1/29/2008

15 %

Cost of products sold 253.9 207.5 22

Gross Profit 819.6 726.1 13

Research and development 50.8 45.6 11

Selling, general and administrative 401.2 345.6 16

Acquisition, integration and other

expense 15.7 (3.4) 576

Operating expenses 467.7 387.8 21

Operating Profit 351.9 338.3 4

Interest income, net 1.1 1.5 (31)

Earnings before income taxes and

minority interest 353.0 339.8 4

Provision for income taxes 89.0 95.0 (6)

Minority interest (0.2) (0.1) (104)

Net Earnings $263.8 $244.7 8

Earnings Per Common Share

Basic $1.13 $1.03 10

Diluted $1.12 $1.02 10

Weighted Average Common Shares

Outstanding

Basic 233.3 238.5

Diluted 234.8 241.0

ZIMMER HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF EARNINGS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2007 and 2006

(in millions, except per share amounts)

2007 2006 % Inc/(Dec)

(unaudited)

Net Sales $3,897.5 $3,495.4 12 %

Cost of products sold 875.9 780.1 12

Gross Profit 3,021.6
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
2. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
3. Zimmer Holdings to Present at JPMorgan Healthcare Conference
4. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings to Present at Upcoming Investor Conferences
7. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
9. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...., Dec. 2 A number of recent publi...hood obesity, the health risks in,overweight chil...reals and,other foods kids consume. Yet one manu... natural, freeze-dried real fruit products that ar...provide most, if not all, of the daily fruit,serv...
(Date:12/2/2008)...hed Call to Action Highlights Need to Reduce Dispa...ational Efforts , , BETHESDA, Md., Dec. 2 ...tious Diseases, (NFID) S.T.O.P. (Share. Teach. O...ed of many of the nation,s leading medical and adv...ion to improve adolescent meningococcal vaccinatio...
(Date:12/2/2008)...ants can help keep driving safe, research shows ,...ivers talking on a cell phone are more distracted ... with a friend sitting next to them in the car, a ... process of joint attention, so when you have a pe...river, that person actually understands something ...
(Date:12/2/2008)...t Expands Leadership Team and Strengthens Commerci...wire/ -- BioNanomatrix, Inc., a developer of break...ics, personalized medicine and biomedical research... Ph.D., as vice president of business development....ess development experience with leading biotechnol...
Breaking Medicine News(10 mins):Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 2Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 3
...ould cut the risk of getting bowel cancer by more...ts do not recommend its continuous use due to poss...t tumors in the lower end of the gastro-intestinal...rs occur in the large intestine and 20 percent in ...
...ric name clopidogrel), the popular anti-blood-clot...ent recommended dose of Plavix to angioplasty pati... risk of heart attack and cardiac death by half. ...assistant professor of medicine at Virginia Common...
...essed over the housing together of two convicted p... Robbie Sebastian Wheeler, 43, and his boyfriend ...her in Hakea jail, in West Australia. The two men...ping a teenage boy and sexually molesting him for ...
... in children, according to a new study by a Housto...the survey studied the dietary intakes of 3,618 ch...t find a relationship between 100 percent juice co...among children," said Theresa Nicklas, a child nut...
Other Medicine News:Health News:Doubling Plavix Dose Recommended Before Angioplasty 2Health News:Outrage Against Gay PartnersInCrime Kept Together 2
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/25/2008)...ewswire-FirstCall/ -- CardioVascular,BioTherapeut...day that it has,dosed the first patient in North ...al trial to treat patients with severe coronary he...tment of CORonary heart Disease) trial will includ...ed doses in approximately 120,patients with sever...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
(Date:11/24/2008)...Cancer Awareness Month , , Oak Brook, Ill.,...Society for Gastrointestinal Endoscopy (ASGE) and ...p this November to raise awareness about pancreati... the resources that are available for them. , ... of cancer deaths in the U.S. In 2008, an estimate...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4Houston Heart Surgeon Elected Vice President of Guatemala 5534 1Houston Heart Surgeon Elected Vice President of Guatemala 5534 2Fragile X Foundations Sign Merger Agreement 5532 1Fragile X Foundations Sign Merger Agreement 5532 2Fragile X Foundations Sign Merger Agreement 5532 3Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 1Baron 26 Budd P C Announces 243 6 Million Settlement in California Asbestos Lawsuit 5530 2
...d at the American College of,Cardiology,s Scientif...RNewswire-FirstCall/ -- CV,Therapeutics, Inc. anno...m the MERLIN TIMI-36 study of ranolazine shows the... patients on ranolazine.,The study did not meet th...the company,s special protocol assessment,agreemen...
...s Across the Genome From 242,Patients and Identifi...astic Leukemia, Suggesting New Targets for Improve...ire/ -- Investigators at,St. Jude Children,s Resea...d mutations that contribute to the formation of pe...st common cancer in,children. The discovery not on...
Other Medicine Technology:CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3Major Gene Study Uncovers Secrets of Leukemia 2Major Gene Study Uncovers Secrets of Leukemia 3
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model.
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Medium 23 mm. Overall length: 3.9 inches.
One end with needle point and other end with medium taper. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches.
Medicine Products: